LDX investor relations just emailed out the recording of the Bell Potter preso.
Not much difference in the repetitive commentary from Doug, but he did confirm that TF is selling both products primarily Viradx.
He also said that the waiver is to start at this stage the second of third week of December. So still a fortnight away from any material update on that.
Hopefully there is an off the cuff announcement out to support some foundation before then.
Add to My Watchlist
What is My Watchlist?
